TLR7 and non-melanoma skin carcinoma: TLR7, which recognizes single-stranded RNA (ssRNA), was also investigated using imiquimod, a TLR7 agonist used clinically to treat non-melanoma skin cancers (NMSCs) (Voiculescu et al, 2019).